Skip to search formSkip to main contentSkip to account menu

IL31 protein, human

Known as: interleukin 31, human, IL-31 protein, human, Interleukin-31 
Interleukin-31 (164 aa, ~18 kDa) is encoded by the human IL31 gene. This protein is involved in signaling during the immune response.
National Institutes of Health

Related topics

Related topics

12 relations
Cell Proliferation Regulatory ProcessCytokine GeneCytokine Receptor BindingCytokine Signaling

Broader (1)

Interleukins

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Potential clinical value of interleukin-31 and interleukin-33 with their receptors expression as diagnostic and predictive factors in endometrial cancer: a case-control study.
Aims: To evaluate the potential role of interleukin-31 and interleukin-33 in diagnosis and prognosis from endometrial cancer… 
2018
2018
Involvement of interleukin‐31 receptor A in morphine‐induced itching and antinociception in mice
Morphine is an effective analgesic for the treatment of severe pain, but it can cause itching in patients. In the present study… 
2018
2018
Immediate‐type allergic and protease‐mediated reactions are involved in scratching behaviour induced by topical application of Dermatophagoides farinae extract in NC/Nga mice
Atopic dermatitis (AD)‐like dermatitis can be induced by repeated topical application of an ointment containing Dermatophagoides… 
2017
2017
Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis.
2015
2015
Cinnamomum cassia bark produced by solid-state fermentation with Phellinus baumii has the potential to alleviate atopic dermatitis-related symptoms.
In order to evaluate whether the aqueous fraction of Cinnamomum cassia produced by solid-state fermentation with Phellinus baumii… 
2014
2014
Increased itching sensation depends on an increase in the dorsal root ganglia IL-31 receptor A (IL-31RA) expression in mice with atopic-like dermatitis
While itching and scratching are important factors in the development of atopic dermatitis (AD), the mechanisms that underlie… 
Review
2013
Review
2013
Potential new therapeutic targets for pathological pruritus.
Very few approved medications are indicated for the treatment of pruritus, and drug development for pruritic diseases is awaited… 
Review
2013
Review
2013
Investigational drugs for pruritus
Introduction: Chronic pruritus (CP), defined as itch lasting for > 6 weeks, is a burdensome symptom of several different diseases… 
2012
2012
IL-31 does not induce normal human ciliated epithelial cells to differentiate into a phenotype consistent with the pathophysiology of asthma.
2011
2011
An H1‐histamine receptor antagonist decreases serum interleukin‐31 levels in patients with atopic dermatitis
MADAM, Atopic dermatitis (AD) is an intractable inflammatory skin disease characterized by an intensely pruritic skin rash with a… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)